The global market for the treatment of anxiety disorders and depression reached a size of USD 18.35 Billion in 2022 and is projected to attain USD 22.92 Billion by 2032. During the forecast period, the market is expected to experience a steady revenue Compound Annual Growth Rate (CAGR) of 2.5%. The driving forces behind this […]
